SE442400B - Forfarande for framstellning av nya 1-aryloxi-2-hydroxi-3-alkylenaminopropaner - Google Patents

Forfarande for framstellning av nya 1-aryloxi-2-hydroxi-3-alkylenaminopropaner

Info

Publication number: SE442400B
Authority: SE; Sweden
Prior art keywords: alkylenaminopropanes; aryloxi; hydroxy; procedure; preparing new
Prior art date: 1976-10-05

Application number

SE7711168A

Other languages

English (en)

Swedish (sv)

Other versions

SE7711168L (sv

Inventor

H Koppe

A Mentrup

E-O Renth

K Schromm

W Hoefke

G Muacevic

Original Assignee

Boehringer Sohn Ingelheim

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1976-10-05

Filing date

1977-10-05

Publication date

1985-12-23

1977-10-05 Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim

1978-05-18 Publication of SE7711168L publication Critical patent/SE7711168L/xx

1985-12-23 Publication of SE442400B publication Critical patent/SE442400B/xx

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, ***e
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C07D233/32—One oxygen atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
- C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
- C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D265/18—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Psychiatry (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Plural Heterocyclic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Quinoline Compounds (AREA)

SE7711168A 1976-10-05 1977-10-05 Forfarande for framstellning av nya 1-aryloxi-2-hydroxi-3-alkylenaminopropaner SE442400B (sv)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE19762644833 DE2644833A1 (de)	1976-10-05	1976-10-05	Neue 1-aryloxy-2-hydroxy-3-alkylenaminopropane und verfahren zu ihrer herstellung

Publications (2)

Publication Number	Publication Date
SE7711168L SE7711168L (sv)	1978-05-18
SE442400B true SE442400B (sv)	1985-12-23

Family

ID=5989679

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SE7711168A SE442400B (sv)	1976-10-05	1977-10-05	Forfarande for framstellning av nya 1-aryloxi-2-hydroxi-3-alkylenaminopropaner

Country Status (33)

Country	Link
US (7)	US4256756A (de)
JP (1)	JPS5368775A (de)
AT (15)	AT361908B (de)
AU (1)	AU514600B2 (de)
BE (1)	BE859415A (de)
BG (1)	BG33153A3 (de)
CA (4)	CA1101859A (de)
CS (1)	CS197304B2 (de)
DD (5)	DD148051A5 (de)
DE (1)	DE2644833A1 (de)
DK (1)	DK439077A (de)
ES (16)	ES462868A1 (de)
FI (1)	FI69066C (de)
FR (1)	FR2394534A1 (de)
GB (3)	GB1592975A (de)
GR (1)	GR64229B (de)
HK (1)	HK19385A (de)
HU (1)	HU177173B (de)
IE (3)	IE46158B1 (de)
IL (1)	IL53043A (de)
LU (1)	LU78240A1 (de)
MY (1)	MY8500909A (de)
NL (1)	NL7710840A (de)
NO (1)	NO151411C (de)
NZ (1)	NZ185356A (de)
PH (4)	PH15763A (de)
PL (1)	PL113879B1 (de)
PT (1)	PT67107B (de)
SE (1)	SE442400B (de)
SG (1)	SG70884G (de)
SU (1)	SU665801A3 (de)
YU (1)	YU40484B (de)
ZA (1)	ZA775905B (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4404380A (en) *	1977-02-14	1983-09-13	Mead Johnson & Company	Triazolopyrimidines
DE2833140A1 (de) *	1978-07-28	1980-02-07	Boehringer Sohn Ingelheim	Neue n-substituierte heterocyclen
SE8003277L (sv) *	1979-05-04	1980-11-05	Continental Pharma	Bensimidazolderivat, deras framstellning och anvendning samt kompositioner innehallande dessa derivat
US4349673A (en) *	1980-12-23	1982-09-14	Merck & Co., Inc.	Benzoxazines
US4656168A (en) *	1980-12-23	1987-04-07	Merck & Co., Inc.	(3-aralkylamino-2-or-propoxy)heterocyclic compounds in method of effecting bronchodilation
US4473501A (en) *	1981-05-04	1984-09-25	G. D. Searle & Co.	Dihydro azino isoquinolines
US4379508A (en) *	1981-10-14	1983-04-12	Nestier Corporation	Nesting tray with stacking keyed interlock
IT1193608B (it) *	1983-01-21	1988-07-21	Pierrel Spa	Derivati di arilossipropanolamina,procedimento per la loro preparazione composizioni farmaceutiche che li contengono e loro impiego terapeutico
DE3324903A1 (de) *	1983-07-09	1985-01-17	Bayer Ag, 5090 Leverkusen	Verfahren zur herstellung substituierter ethylenharnstoffe sowie neue n-vinylethylenharnstoffe
GB8419797D0 (en) *	1984-08-03	1984-09-05	Beecham Group Plc	Compounds
DE3807922A1 (de) *	1988-03-10	1989-09-21	Boehringer Mannheim Gmbh	Substituierte heterocyclen, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten
TW203049B (de) *	1990-04-13	1993-04-01	Yamanouchi Pharma Co Ltd
US6860524B1 (en)	1993-05-14	2005-03-01	William W. Rowley	Polyolefin connectors
US6557907B2 (en)	1993-05-14	2003-05-06	William W. Rowley	Polyethylene connectors
CA2330611A1 (en)	1998-05-22	1999-12-02	The Board Of Trustees Of The Leland Stanford Junior University	Bifunctional molecules and therapies based thereon
ATE445838T1 (de)	2001-07-25	2009-10-15	Raptor Pharmaceutical Inc	Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
US6848719B2 (en)	2001-09-06	2005-02-01	William W. Rowley	Bendable polymer-lined water heater connector
AR042132A1 (es) *	2002-11-26	2005-06-08	Smithkline Beecham Corp	Compuesto de 2- hidroxi -3-(2- aril - 1, 1 - dimetiletilamino) propoxifenilo, composicion farmaceutica que lo comprende y uso del mismo para prepararla
EP1575923A2 (de) *	2002-12-23	2005-09-21	Artesian Therapeutics, Inc.	Kardiotonische verbindungen mit inhibitorische aktivität gegenüber beta adrenergen rezeptoren und phosphodiesterase
DE102004045648A1 (de) *	2004-09-21	2006-03-23	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue Betamimetika zur Behandlung von Atemwegserkrankungen
EP1833480A2 (de) *	2004-11-30	2007-09-19	Artesian Therapeutics, Inc.	Kardiotonische verbindungen mit hemmwirkung gegen beta-adrenerge rezeptor und phosphodiesterase
DK1889198T3 (da)	2005-04-28	2015-02-09	Proteus Digital Health Inc	Farma-informatiksystem
WO2008036682A2 (en)	2006-09-18	2008-03-27	Raptor Pharmaceutical Inc.	Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
US8993641B2 (en) *	2007-11-29	2015-03-31	Innolex Investment Corporation	Preservation of cosmetics, toiletry and pharmaceutical compositions
ES2728225T3 (es)	2009-02-20	2019-10-23	2 Bbb Medicines B V	Sistema de administración de fármacos a base de glutatión
US8445002B2 (en)	2009-05-06	2013-05-21	Laboratory Skin Care, Inc.	Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US20120077778A1 (en)	2010-09-29	2012-03-29	Andrea Bourdelais	Ladder-Frame Polyether Conjugates

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL284529A (de) *	1961-10-24
GB1066613A (en) *	1965-03-03	1967-04-26	Ici Ltd	Naphthalene derivatives
GB1349358A (en) *	1969-11-28	1974-04-03	Teikoku Hormone Mfg Co Ltd	Hydrogenation process
ZA71932B (en) *	1970-02-27	1971-10-27	Ici Ltd	Organic compounds
BE787103A (fr) *	1971-08-04	1973-02-02	Pfizer	Nouveaux derives de propanolamine et composition pharmaceutiqueles contenant
US3818017A (en) *	1973-01-04	1974-06-18	Janssen Pharmaceutica Nv	1-{8 1-(2-hydroxy-3-aryloxypropyl)-4-piperidyl{9 -2-benzimidazolinones and related compounds
US3894030A (en) *	1973-01-04	1975-07-08	Janssen Pharmaceutica Nv	1-{8 1-(2-Hydroxy-3-aryloxypropyl)-4-piperidyl{9 -2-benzimidazolinones and related compounds
GB1456525A (en) *	1973-07-18	1976-11-24	Ici Ltd	Process for the manufacture of alkanolamine derivatives
DE2503222A1 (de) *	1975-01-27	1976-07-29	Boehringer Sohn Ingelheim	Verfahren zur herstellung von 1-aryl- oxy-3-n-substituierten aminopropanderivaten
US4081447A (en) *	1975-04-09	1978-03-28	Abbott Laboratories	5-[2-Hydroxy-3-(3,4-dimethoxy phenethylamino)]-propoxy-3,4-dihydro carbostyril and pharmaceutically acceptable salts thereof
CH624395A5 (de) *	1976-01-08	1981-07-31	Ciba Geigy Ag
DE2609645A1 (de) *	1976-03-09	1977-09-15	Boehringer Sohn Ingelheim	Aminoalkylheterocyclen

1976
- 1976-10-05 DE DE19762644833 patent/DE2644833A1/de not_active Withdrawn
1977
- 1977-09-22 AT AT679377A patent/AT361908B/de not_active IP Right Cessation
- 1977-09-26 FI FI772823A patent/FI69066C/fi not_active IP Right Cessation
- 1977-10-03 PT PT67107A patent/PT67107B/de unknown
- 1977-10-03 DD DD77217956A patent/DD148051A5/de unknown
- 1977-10-03 DD DD77217954A patent/DD148050A5/de unknown
- 1977-10-03 DD DD77212491A patent/DD143074A5/de unknown
- 1977-10-03 DD DD77201314A patent/DD134642A5/de unknown
- 1977-10-03 IL IL53043A patent/IL53043A/xx unknown
- 1977-10-03 DD DD77217961A patent/DD148052A5/de unknown
- 1977-10-03 LU LU7778240A patent/LU78240A1/xx unknown
- 1977-10-03 BG BG7737483A patent/BG33153A3/xx unknown
- 1977-10-03 HU HU77BO1685A patent/HU177173B/hu unknown
- 1977-10-04 DK DK439077A patent/DK439077A/da not_active Application Discontinuation
- 1977-10-04 NO NO773384A patent/NO151411C/no unknown
- 1977-10-04 GR GR54491A patent/GR64229B/el unknown
- 1977-10-04 GB GB41251/77A patent/GB1592975A/en not_active Expired
- 1977-10-04 SU SU772527654A patent/SU665801A3/ru active
- 1977-10-04 CA CA288,058A patent/CA1101859A/en not_active Expired
- 1977-10-04 NL NL7710840A patent/NL7710840A/xx not_active Application Discontinuation
- 1977-10-04 ES ES462868A patent/ES462868A1/es not_active Expired
- 1977-10-04 GB GB41738/79A patent/GB1592977A/en not_active Expired
- 1977-10-04 ZA ZA00775905A patent/ZA775905B/xx unknown
- 1977-10-04 JP JP11938777A patent/JPS5368775A/ja active Granted
- 1977-10-04 YU YU2369/77A patent/YU40484B/xx unknown
- 1977-10-04 AU AU29333/77A patent/AU514600B2/en not_active Expired
- 1977-10-04 PL PL1977201286A patent/PL113879B1/pl unknown
- 1977-10-04 GB GB41737/79A patent/GB1592976A/en not_active Expired
- 1977-10-05 CS CS776449A patent/CS197304B2/cs unknown
- 1977-10-05 NZ NZ185356A patent/NZ185356A/xx unknown
- 1977-10-05 IE IE2038/77A patent/IE46158B1/en unknown
- 1977-10-05 IE IE2409/82A patent/IE46159B1/en unknown
- 1977-10-05 FR FR7729973A patent/FR2394534A1/fr active Granted
- 1977-10-05 BE BE181490A patent/BE859415A/xx not_active IP Right Cessation
- 1977-10-05 SE SE7711168A patent/SE442400B/xx not_active IP Right Cessation
- 1977-10-05 IE IE2410/82A patent/IE46160B1/en unknown
1978
- 1978-07-17 ES ES471794A patent/ES471794A1/es not_active Expired
- 1978-07-17 ES ES471798A patent/ES471798A1/es not_active Expired
- 1978-07-17 ES ES471804A patent/ES471804A1/es not_active Expired
- 1978-07-17 ES ES471795A patent/ES471795A1/es not_active Expired
- 1978-07-17 ES ES471803A patent/ES471803A1/es not_active Expired
- 1978-07-17 ES ES471797A patent/ES471797A1/es not_active Expired
- 1978-07-17 ES ES471802A patent/ES471802A1/es not_active Expired
- 1978-07-17 ES ES471801A patent/ES471801A1/es not_active Expired
- 1978-07-17 ES ES471808A patent/ES471808A1/es not_active Expired
- 1978-07-17 ES ES471806A patent/ES471806A1/es not_active Expired
- 1978-07-17 ES ES471800A patent/ES471800A1/es not_active Expired
- 1978-07-17 ES ES471807A patent/ES471807A1/es not_active Expired
- 1978-07-17 ES ES471796A patent/ES471796A1/es not_active Expired
- 1978-07-17 ES ES471805A patent/ES471805A1/es not_active Expired
- 1978-07-17 ES ES471799A patent/ES471799A1/es not_active Expired
1979
- 1979-01-17 US US06/004,279 patent/US4256756A/en not_active Expired - Lifetime
- 1979-01-17 US US06/004,280 patent/US4212877A/en not_active Expired - Lifetime
- 1979-08-30 PH PH22979A patent/PH15763A/en unknown
- 1979-12-14 US US06/103,724 patent/US4255430A/en not_active Expired - Lifetime
1980
- 1980-01-16 US US06/112,640 patent/US4296117A/en not_active Expired - Lifetime
- 1980-02-04 AT AT0057680A patent/AT363080B/de not_active IP Right Cessation
- 1980-02-04 AT AT56880A patent/AT361912B/de not_active IP Right Cessation
- 1980-02-04 AT AT0057780A patent/AT363081B/de not_active IP Right Cessation
- 1980-02-04 AT AT56980A patent/AT361913B/de not_active IP Right Cessation
- 1980-02-04 AT AT57080A patent/AT361914B/de not_active IP Right Cessation
- 1980-02-04 AT AT57380A patent/AT362363B/de not_active IP Right Cessation
- 1980-02-04 AT AT0058080A patent/AT364828B/de not_active IP Right Cessation
- 1980-02-04 AT AT57880A patent/AT362365B/de not_active IP Right Cessation
- 1980-02-04 AT AT0057980A patent/AT363082B/de not_active IP Right Cessation
- 1980-02-04 AT AT56780A patent/AT361911B/de not_active IP Right Cessation
- 1980-02-04 AT AT57280A patent/AT362362B/de not_active IP Right Cessation
- 1980-02-04 AT AT57480A patent/AT362364B/de not_active IP Right Cessation
- 1980-02-04 AT AT57180A patent/AT361915B/de not_active IP Right Cessation
- 1980-02-04 AT AT0057580A patent/AT363079B/de not_active IP Right Cessation
- 1980-10-09 US US06/195,650 patent/US4381309A/en not_active Expired - Lifetime
- 1980-10-09 PH PH24696A patent/PH16053A/en unknown
1981
- 1981-02-05 CA CA370,238A patent/CA1125751A/en not_active Expired
- 1981-02-05 CA CA370,237A patent/CA1126271A/en not_active Expired
- 1981-02-05 CA CA370,239A patent/CA1127643A/en not_active Expired
- 1981-04-20 US US06/255,751 patent/US4343800A/en not_active Expired - Fee Related
1982
- 1982-05-10 PH PH27256A patent/PH18363A/en unknown
- 1982-11-11 PH PH28126A patent/PH19028A/en unknown
1984
- 1984-07-25 US US06/634,446 patent/US4604468A/en not_active Expired - Fee Related
- 1984-10-05 SG SG708/84A patent/SG70884G/en unknown
1985
- 1985-03-14 HK HK193/85A patent/HK19385A/xx unknown
- 1985-12-30 MY MY909/85A patent/MY8500909A/xx unknown

Also Published As

Publication number	Publication date
LU78240A1 (de)	1979-02-02
FI69066B (fi)	1985-08-30
ES462868A1 (es)	1978-12-16
JPS5368775A (en)	1978-06-19
ATA679377A (de)	1980-09-15
ATA57580A (de)	1980-12-15
ES471806A1 (es)	1979-02-01
ATA57280A (de)	1980-10-15
NO151411B (no)	1984-12-27
PL113879B1 (en)	1981-01-31
IE46160B1 (en)	1983-03-09
HK19385A (en)	1985-03-22
ES471805A1 (es)	1979-02-01
ATA57880A (de)	1980-10-15
IL53043A (en)	1982-01-31
CA1127643A (en)	1982-07-13
ES471801A1 (es)	1979-02-01
DK439077A (da)	1978-04-06
AU514600B2 (en)	1981-02-19
SE7711168L (sv)	1978-05-18
FR2394534B1 (de)	1982-04-30
FI69066C (fi)	1985-12-10
PH18363A (en)	1985-06-13
DD148051A5 (de)	1981-05-06
DD148050A5 (de)	1981-05-06
CS197304B2 (en)	1980-04-30
ES471807A1 (es)	1979-02-01
DD134642A5 (de)	1979-03-14
ATA58080A (de)	1981-04-15
ES471795A1 (es)	1979-02-01
US4296117A (en)	1981-10-20
AT361914B (de)	1981-04-10
ES471794A1 (es)	1979-02-01
US4256756A (en)	1981-03-17
ES471797A1 (es)	1979-02-01
US4343800A (en)	1982-08-10
ATA56780A (de)	1980-09-15
ES471796A1 (es)	1979-02-01
MY8500909A (en)	1985-12-31
ES471808A1 (es)	1979-02-01
GB1592975A (en)	1981-07-15
SG70884G (en)	1985-04-04
AT362364B (de)	1981-05-11
BG33153A3 (en)	1982-12-15
ATA57480A (de)	1980-10-15
ATA57680A (de)	1980-12-15
ATA57180A (de)	1980-09-15
IE822409L (en)	1978-04-05
AT362362B (de)	1981-05-11
NL7710840A (nl)	1978-04-07
IE46158L (en)	1978-04-05
ES471798A1 (es)	1979-02-01
US4381309A (en)	1983-04-26
AT363082B (de)	1981-07-10
ES471803A1 (es)	1979-02-01
FI772823A (fi)	1978-04-06
JPS6210988B2 (de)	1987-03-10
AU2933377A (en)	1979-04-12
IE822410L (en)	1978-04-05
ATA57380A (de)	1980-10-15
ATA57080A (de)	1980-09-15
IL53043A0 (en)	1977-12-30
DE2644833A1 (de)	1978-04-20
BE859415A (fr)	1978-04-05
AT362365B (de)	1981-05-11
ES471804A1 (es)	1979-02-01
AT361915B (de)	1981-04-10
NO151411C (no)	1985-04-10
AT361911B (de)	1981-04-10
AT363081B (de)	1981-07-10
PH16053A (en)	1983-06-09
GB1592976A (en)	1981-07-15
US4604468A (en)	1986-08-05
AT363079B (de)	1981-07-10
ATA56980A (de)	1980-09-15
AT361913B (de)	1981-04-10
ES471800A1 (es)	1979-02-01
PT67107B (de)	1980-04-07
AT361912B (de)	1981-04-10
IE46159B1 (en)	1983-03-09
ES471799A1 (es)	1979-02-01
NO773384L (no)	1978-04-06
AT361908B (de)	1981-04-10
ATA56880A (de)	1980-09-15
PH19028A (en)	1985-12-06
AT362363B (de)	1981-05-11
AT364828B (de)	1981-11-25
PL201286A1 (pl)	1978-12-04
ES471802A1 (es)	1979-02-01
DD143074A5 (de)	1980-07-30
NZ185356A (en)	1981-05-01
ZA775905B (en)	1979-06-27
ATA57780A (de)	1980-12-15
FR2394534A1 (fr)	1979-01-12
PH15763A (en)	1983-03-22
DD148052A5 (de)	1981-05-06
HU177173B (en)	1981-08-28
AT363080B (de)	1981-07-10
YU40484B (en)	1986-02-28
ATA57980A (de)	1980-12-15
US4255430A (en)	1981-03-10
IE46158B1 (en)	1983-03-09
GB1592977A (en)	1981-07-15
CA1126271A (en)	1982-06-22
CA1125751A (en)	1982-06-15
YU236977A (en)	1983-01-21
CA1101859A (en)	1981-05-26
GR64229B (en)	1980-02-14
US4212877A (en)	1980-07-15
SU665801A3 (ru)	1979-05-30
PT67107A (de)	1977-11-01

Legal Events

Date

Code

Title

Description

1995-01-31

NUG

Patent has lapsed

Ref document number: 7711168-0

Effective date: 19880627

Format of ref document f/p: F

Publication	Publication Date	Title
SE442400B (sv)	1985-12-23	Forfarande for framstellning av nya 1-aryloxi-2-hydroxi-3-alkylenaminopropaner
SE440791B (sv)	1985-08-19	Forfarande for upparbetning av lignitkol
SE440501B (sv)	1985-08-05	Forfarande for framstellning av substituerade fenylamidoximer
NO773548L (no)	1978-04-19	Fremgangsmaate for fremstilling av spiro-hydantoinderivater
SE440772B (sv)	1985-08-19	Forfarande for framstellning av nya 1-naftylmetyl-cinnamyl-aminderivat
SE434057B (sv)	1984-07-02	Forfarande for framstellning av nya rifamycinforeningar
FI772915A (fi)	1978-04-06	Foerfarande foer framstaellning av nya antracyklinantibiotika
SE437515B (sv)	1985-03-04	Forfarande for framstellning av nya fenyletylaminer
FI55353B (fi)	1979-03-30	Foerfarande foer framstaellning av nya antracyklinantibiotika
SE7704545L (sv)	1977-10-25	Forfarande for framstellning av nya adeninderivat
SE433212B (sv)	1984-05-14	Forfarande for framstellning av 4-hydroxi-aporfin-derivat
IT1076788B (it)	1985-04-27	Procedimento per preparare organopolisilossani
SE7704139L (sv)	1977-10-10	Forfarande for framstellning av azofergemnen
SE431871B (sv)	1984-03-05	Forfarande for framstellning av 2-brom-6-fluor-n-2-imidazolidinylidenbensamin
SE7614264L (sv)	1977-07-23	Forfarande for framstellning av nya 17-estrar av 17alfa-hydroxigestogener
SE433220B (sv)	1984-05-14	Forfarande for framstellning av nya pregnan-derivat
SE433219B (sv)	1984-05-14	Forfarande for framstellning av 3-halogenmetylcefalosporinforeningar
SE443140B (sv)	1986-02-17	Forfarande for framstellning av karbostyrilderivat
FI772565A (fi)	1978-03-01	Foerfarande foer framstaellning av nya bensopyranderivat
SE7703634L (sv)	1977-10-01	Forfarande for framstellning av nya amidinopenicillanoyloxialkylamoxicillinater
SE440903B (sv)	1985-08-26	Forfarande for framstellning av nya 1-aryloxi-2-hydroxi-3-aminopropaner
SE421125B (sv)	1981-11-30	Forfarande for framstellning av 5-m-tolyloxiuracil
SE7700824L (sv)	1977-07-28	Forfarande for framstellning av nya kromaner
NO773073L (no)	1978-03-21	Fremgangsmaate for fremstilling av 2-piperazinyl-kinazolinderivater
SE418287B (sv)	1981-05-18	Forfarande for framstellning av guajakol-p-isobutyl-hydratropat